These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 233817)

  • 21. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced activity of pyrimidine 5'-nucleotidase in rat red blood cells during erythropoiesis.
    Hokari S; Miyazaki T; Hasegawa M; Komoda T
    Biol Chem; 1998 Mar; 379(3):329-33. PubMed ID: 9563829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
    Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
    Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of pyrimidine 5'-nucleotidase subclass I during erythrocyte maturation in rats.
    Hokari S; Miyazaki T; Matsunaga T; Koyama I; Hasegawa M; Komoda T
    J Hematother Stem Cell Res; 2001 Oct; 10(5):703-7. PubMed ID: 11672517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro and in vivo effects of lead on delta-aminolevulinic acid dehydratase and pyrimidine 5'-nucleotidase.
    Ong CN; Kong YM; Ong HY; Teramoto K
    Pharmacol Toxicol; 1990 Jan; 66(1):23-6. PubMed ID: 2308903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of lead exposure in workers at secondary lead smelters in South Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Lee H; Lee CR; Park DU; Yang JS; Park IJ; Lee KY; Lee M; Kim TK; Sohn NS; Cho YS; Lee N; Chung HK
    Sci Total Environ; 2002 Mar; 286(1-3):181-9. PubMed ID: 11886093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
    Hirono A; Fujii H; Miwa S
    Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
    Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
    S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
    Ichiba M; Tomokuni K
    Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythrocyte nucleotides from control and lead-treated rabbits.
    Swanson MS; Angle CR; Stohs SJ; Rovang KS
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of lead intoxication: clinical and biochemical studies.
    Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
    Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chicken erythrocyte pyrimidine 5'-nucleotidase: purification and characterization of the subclass I enzyme.
    Hokari S; Miyazaki T; Hasegawa M; Koyama L; Komoda T
    Biol Chem; 2001 Jun; 382(6):919-24. PubMed ID: 11501756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro effect of 13 metals on the activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Oishi H; Ichiba M; Tomokuni K
    J Toxicol Sci; 1994 Nov; 19(4):197-201. PubMed ID: 7884830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrimidine 5'nucleotidase and several other red cell enzyme activities in beta-thalassaemia trait.
    Vives Corrons JL; Pujades MA; Aguilar i Bascompte JL; Jou JM; Rozman C; Ester A
    Br J Haematol; 1984 Mar; 56(3):483-94. PubMed ID: 6320862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of pyrimidine 5'nucleotidase activity in erythrocytes of sheep, dogs, cats, horses, calves, and Mongolian gerbils.
    George JW; Duncan JR; Mahaffey EA
    Am J Vet Res; 1983 Oct; 44(10):1968-70. PubMed ID: 6314858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lead exposure on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase in mice.
    Tomokuni K
    Tohoku J Exp Med; 1983 Jan; 139(1):27-32. PubMed ID: 6301100
    [No Abstract]   [Full Text] [Related]  

  • 38. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between lead concentration in blood and the activities of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the mice exposed to lead.
    Tomokuni K; Ogata M
    Arch Toxicol; 1981 Mar; 47(1):67-9. PubMed ID: 6269517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.
    de Korte D; van Doorn CC; Sijstermans JM; van Gennip AH; Roos D
    J Inherit Metab Dis; 1989; 12(3):267-72. PubMed ID: 2559246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.